Institutional investors control 46.66% of the outstanding shares in SNSS. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2017, these large investors purchased a net $1.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RA CAPITAL MANAGEMENT LLC Bought 2.3 Million shares of Sunesis Pharmaceuticals I...